RTS，S／AS01疟疾疫苗Ⅲ期临床研究取得积极结果
被引量：1
摘要
在撒哈拉以南非洲地区7个国家15460名儿童中进行的RTS，S／AS01疟疾疫苗首次大规模Ⅲ期临床试验的初步结果显示，大年龄组6000名5～17月龄儿童接种3剂疫苗后，在12个月随访期内，罹患临床疟疾和严重疟疾的风险分别降低了56％和47％，疫苗在该年龄段儿童中具有良好的安全性和免疫原性，
出处
《国际生物制品学杂志》
CAS
2011年第6期296-296,共1页
International Journal of Biologicals
同被引文献40
-
1World Health Organization. World malaria report 2011 [ R ]. Geneva: WHO, 2011 : 12.
-
2Ballou WR, Rothbard J, Wirtz RA, et al. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum[J]. Science, 1985,228(4702) :996-999.
-
3Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial [J]. Lancet, 2004,364(9443 ) : 1411-1420.
-
4Bejon P, Lusingu J, Olotu A, et al. Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age [J]. N Engl J Med,2008,359(24) : 2521-2532. S.
-
5acarlal J, Aide P, Aponte J J, et al. Long-term safety and efficacy of the RTS, S/AS02A malaria vaccine in Mozambican children[J]. J Infect Dis, 2009,200(3) : 329-336.
-
6Heppner DG Jr, Kester KE, Ockenhouse CF, et al. Towards an RTS, S-based, multi-stage, multiantigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research [ J ]. Vaccine, 2005,23 ( 17/18 ) : 2243-2250.
-
7Stewart VA, McGrath SM, Dubois PM, et al. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS, S/ASO1B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone [ J ]. Infect Immun, 2007,75 (5) : 2283-2290.
-
8World Health Organization. Initiative for vaccine research : malaria vaccines. 2010[EB/OL]. [2011-08-17]. Available at http://www. who.int/vaeeine_research/links/Rainbow/en/index.html.
-
9Cummings JF, Spring MD, Schwenk RJ, et al. Recombinant liver stage antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN- gamma/IL-2 CD4 T cells but does not protect against experimental Plasmodium falciparum infection [ J ]. Vaccine, 201 O, 28 (31 ) : 5135-5144.
-
10Hill AV, Reyes-Sandoval A, O' Hara G, et al. Prime-boost vectored malaria vaccines : progress and prospects [J]. Hum Vaccin, 2010,6 (1) 78-83.
二级引证文献3
-
1李作伟,李平.中西医结合治疗非洲疟疾发热患者的研究进展[J].医疗装备,2016,29(22):199-200. 被引量：1
-
2刘群,何隆华.水域环境对蚊密度影响研究进展[J].中国媒介生物学及控制杂志,2018,29(4):413-417. 被引量：4
-
3陈浩,崔淑君,肖朝江,姜北.抗疟药物筛选方法的研究进展[J].中南药学,2020,18(7):1210-1214.
-
1魏岳江.丈夫患艾滋妻子怎么办[J].大众健康,2010(12):124-125.
-
2梁涛,荆晶.疟疾可能加速艾滋病在非洲的传播[J].中国医药指南,2007,5(1):89-89.
-
3联合国帮助非洲儿童远离艾滋病[J].中外健康文摘,2008,5(9).
-
4艾滋病常见问题解答（二）[J].疾病监测,2011,26(11):860-860.
-
5全球3300多万人感染艾滋病病毒[J].医院管理论坛,2007,24(12):7-7.
-
6王永怡,陈文.女性HIV感染的相关问题研究[J].传染病信息,2008,21(3):182-185.
-
7向感染HIV的青少年提供基于权利的服务[J].中国计划生育学杂志,2014,22(4):276-276.
-
8许关煜（编译）.RTS，S／AS02[J].中国处方药,2007(10):15-15.
-
9适当暂停艾滋病治疗对患者健康没有损害[J].中国医药指南,2006,4(9):109-109.
-
10适当暂停艾滋病治疗对患者健康没有损害[J].传染病网络动态,2006(9):12-12.
